Our Pricing

Omeprazole vs Gaviscon: Comparing Acid Reflux Treatments

Published on: June 03, 2026

When comparing omeprazole vs Gaviscon UK treatments, understanding the fundamental differences between proton pump inhibitors and antacids is essential for effective symptom management. Omeprazole reduces stomach acid production at the source, whilst Gaviscon neutralises existing acid and forms a protective barrier. At Cured Pharmacy, our UK-registered prescribers help you determine which approach—or combination—best suits your individual symptoms and lifestyle.

How Omeprazole and Gaviscon Work Differently

Omeprazole belongs to a class of medicines called proton pump inhibitors (PPIs), which work by blocking the enzyme system responsible for producing stomach acid [1]. By inhibiting the hydrogen-potassium ATPase pump in gastric parietal cells, omeprazole can reduce acid secretion by up to 90% within 24 hours, providing sustained relief for moderate to severe gastro-oesophageal reflux disease (GORD) [1].

Gaviscon, by contrast, is an alginate-based antacid that works through a different mechanism entirely. When Gaviscon enters the stomach, it reacts with gastric acid to form a protective raft that floats on top of stomach contents [2]. This physical barrier helps prevent acid from refluxing into the oesophagus whilst simultaneously neutralising existing acid. The effect is rapid—typically within minutes—but shorter-lasting than PPIs, making Gaviscon ideal for immediate symptom relief rather than long-term acid suppression.

Omeprazole vs Gaviscon: Speed and Duration of Relief

The most significant practical difference between omeprazole and Gaviscon lies in their onset and duration of action. Gaviscon provides relief within 3-5 minutes of administration, making it highly effective for acute heartburn episodes after meals or when lying down [2]. However, this relief typically lasts only 3-4 hours, requiring multiple daily doses for continuous symptom control.

Omeprazole requires 1-4 days to reach full therapeutic effect, as it must accumulate in parietal cells and irreversibly bind to proton pumps [1]. Whilst this delayed onset may seem disadvantageous, omeprazole provides 24-hour acid suppression with a single daily dose. Clinical studies demonstrate that omeprazole 20mg once daily achieves complete heartburn resolution in 75-85% of GORD patients within four weeks [3].

When to Choose Immediate vs Sustained Relief

For occasional heartburn triggered by specific foods or activities, Gaviscon's rapid action makes it the preferred first-line option. Patients experiencing symptoms fewer than twice weekly often achieve adequate control with on-demand antacid use. However, if you're using Gaviscon daily for more than two weeks, or experiencing night-time symptoms that disrupt sleep, omeprazole or another PPI may provide more appropriate long-term management. Our UK prescribers at Cured Pharmacy assess symptom frequency, severity, and lifestyle factors to recommend the most suitable treatment approach.

Which Conditions Respond Better to Omeprazole or Gaviscon

Gaviscon is particularly effective for postprandial heartburn (symptoms occurring after eating) and pregnancy-related reflux, where the mechanical barrier effect addresses reflux caused by increased abdominal pressure rather than excessive acid production [2]. It's also suitable for patients with mild, intermittent symptoms who prefer non-systemic medication without the need for prescription assessment.

Omeprazole demonstrates superior efficacy for erosive oesophagitis, Barrett's oesophagus surveillance, and frequent reflux symptoms occurring three or more times weekly [3]. The MHRA has licensed omeprazole for both treatment and prevention of GORD symptoms, with clinical evidence supporting healing rates of 80-90% for oesophageal erosions within eight weeks at standard doses [1][3]. Patients with documented hiatus hernia, nocturnal reflux, or those requiring long-term acid suppression for oesophageal protection typically benefit more from PPI therapy than antacids alone.

Combination Therapy: Using Both Treatments Together

Many patients successfully use omeprazole for baseline acid control whilst keeping Gaviscon available for breakthrough symptoms. This combination approach is clinically appropriate and often recommended during the initial days of PPI therapy, when full acid suppression has not yet been achieved. Your prescriber may also suggest Gaviscon for specific situations—such as after particularly rich meals or before lying down—even when taking regular omeprazole. At Cured Pharmacy, our clinical team provides personalised guidance on optimising both medications for your individual symptom pattern.

Side Effects and Safety Considerations

Gaviscon has an excellent safety profile with minimal systemic absorption, making it suitable for short-term use in most patient groups, including pregnant and breastfeeding women (subject to prescriber approval) [2]. The most common considerations involve sodium content in some formulations, which may be relevant for patients on sodium-restricted diets, and potential interactions with other medications due to altered gastric pH affecting drug absorption.

Omeprazole is generally well-tolerated, with headache, gastrointestinal disturbances, and dizziness reported in approximately 1-10% of patients [1]. Long-term PPI use (beyond 12 months) requires periodic review by a healthcare professional, as extended acid suppression may be associated with reduced vitamin B12 and magnesium absorption, and slightly increased infection risk due to reduced gastric acid barrier function [4]. NICE guidance recommends using the lowest effective PPI dose for the shortest duration necessary to control symptoms.

Cost and Accessibility: Omeprazole vs Gaviscon UK Options

Gaviscon is available over-the-counter at most UK pharmacies without prescription, with prices varying by formulation and pack size. This accessibility makes it convenient for immediate symptom relief without clinical consultation. However, frequent purchases for daily use can accumulate significant ongoing costs compared to prescription alternatives.

Omeprazole 10mg is available over-the-counter for short-term use (up to 4 weeks), whilst higher strengths and extended treatment courses require prescription from a UK-registered prescriber. At Cured Pharmacy, omeprazole capsules start from £9.99 following a free online clinical assessment completed in under three minutes. Our transparent upfront pricing includes both medication and prescriber consultation, with no hidden fees. We also offer alternative PPIs including esomeprazole from £9.99, lansoprazole from £9.99, and pantoprazole from £9.99, allowing your prescriber to select the most clinically appropriate and cost-effective option for your needs.

Accessing Treatment Through Cured Pharmacy

All prescription acid reflux treatments at Cured Pharmacy require completion of a brief online medical questionnaire reviewed by our UK-registered clinical team. This ensures omeprazole and other PPIs are prescribed safely, with consideration of your medical history, current medications, and symptom characteristics. Once approved, your treatment is dispensed by our GPhC-registered pharmacy (9012511) and delivered in 100% discreet packaging, typically within 1-3 working days across the UK.

Making the Right Choice for Your Acid Reflux Symptoms

The decision between omeprazole and Gaviscon ultimately depends on your symptom frequency, severity, and treatment goals. If you experience heartburn fewer than twice weekly, triggered by identifiable foods or activities, Gaviscon provides effective on-demand relief without the need for daily medication. Its rapid action and excellent safety profile make it ideal for intermittent symptom management.

For patients with frequent symptoms (three or more episodes weekly), night-time reflux, or inadequate response to antacids, omeprazole or another PPI offers more comprehensive acid control. Clinical evidence consistently demonstrates superior symptom resolution and oesophageal healing with PPI therapy compared to antacids alone in moderate to severe GORD [3][4]. Our prescribers at Cured Pharmacy conduct thorough assessments to determine whether your symptoms warrant PPI treatment, or whether lifestyle modifications and on-demand antacids may suffice. We're committed to evidence-based prescribing that balances clinical effectiveness with appropriate medication use, ensuring you receive the right treatment at the right time.

Scientific References

1. Strand, D. S., Kim, D., & Peura, D. A. (2017). 25 Years of Proton Pump Inhibitors: A Comprehensive Review. Gut and Liver, 11(1), 27-37. https://doi.org/10.5009/gnl15502 [accessed 13 August 2026]
2. Kwiatek, M. A., Roman, S., Fareeduddin, A., Pandolfino, J. E., & Kahrilas, P. J. (2011). An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial 'acid pocket' in symptomatic GERD patients. Alimentary Pharmacology & Therapeutics, 34(1), 59-66. https://doi.org/10.1111/j.1365-2036.2011.04678.x [accessed 13 August 2026]
3. National Institute for Health and Care Excellence. (2014). Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management (Clinical guideline CG184). NICE. https://www.nice.org.uk/guidance/cg184 [accessed 13 August 2026]
4. Freedberg, D. E., Kim, L. S., & Yang, Y. X. (2017). The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association. Gastroenterology, 152(4), 706-715. https://doi.org/10.1053/j.gastro.2017.01.031 [accessed 13 August 2026]
5. NHS. (2026). Heartburn and acid reflux. https://www.nhs.uk/conditions/heartburn-and-acid-reflux/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and treatment suitability depends on your medical history and current health status.